[go: up one dir, main page]

BR0101230A - Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina - Google Patents

Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina

Info

Publication number
BR0101230A
BR0101230A BR0101230-4A BR0101230A BR0101230A BR 0101230 A BR0101230 A BR 0101230A BR 0101230 A BR0101230 A BR 0101230A BR 0101230 A BR0101230 A BR 0101230A
Authority
BR
Brazil
Prior art keywords
synthesis
application
detianeptine
thiazepine
dibenzo
Prior art date
Application number
BR0101230-4A
Other languages
English (en)
Other versions
BR0101230B1 (pt
Inventor
Jacky Blanchard
Hugues Turbe
Daniel Brigot
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of BR0101230A publication Critical patent/BR0101230A/pt
Publication of BR0101230B1 publication Critical patent/BR0101230B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Patente de Invenção: "PROCESSO PARA A PREPARAçãO DE11-AMINO3-CLORO-6,11-DIIDRO-5,5-DIOXO-6-METIL-DIBENZO[c,f][1,2]TIAZEPINA E APLICAçãO PARA A SìNTESE DETIANEPTINA". Processo para a síntese industrial do composto defórmula (I) : e seus sais de adição. Aplicação para a síntese detianeptina e seus sais farmaceuticamente aceitáveis.
BRPI0101230-4B1A 2000-03-31 2001-03-29 PROCESSO PARA A PREPARAÇÃO DE TIANEPTINA E SEUS SAIS FARMACEUTICAMENTE ACEITÁVEIS E DE 11-AMINO-3- CLORO 6,11-DIIDRO-5,5-DIOXO-6-METIL-DIBENZO[c,f][1,2]-TIAZEPINA BR0101230B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0004111A FR2807039A1 (fr) 2000-03-31 2000-03-31 NOUVEAU PROCEDE DE PREPARATION DE LA 11-AMINO-3-CHLORO-6,11- DIHYDRO-5,5-DIOXO-6-METHYL-DIBENZO[c,f][1,2]-THIAZEPINE ET APPLICATION A LA SYNTHESE DE LA TIANEPTINE

Publications (2)

Publication Number Publication Date
BR0101230A true BR0101230A (pt) 2001-10-30
BR0101230B1 BR0101230B1 (pt) 2013-12-24

Family

ID=8848710

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0101230-4B1A BR0101230B1 (pt) 2000-03-31 2001-03-29 PROCESSO PARA A PREPARAÇÃO DE TIANEPTINA E SEUS SAIS FARMACEUTICAMENTE ACEITÁVEIS E DE 11-AMINO-3- CLORO 6,11-DIIDRO-5,5-DIOXO-6-METIL-DIBENZO[c,f][1,2]-TIAZEPINA

Country Status (23)

Country Link
US (1) US6441165B2 (pt)
EP (1) EP1138677B1 (pt)
JP (1) JP3723464B2 (pt)
KR (1) KR100464180B1 (pt)
CN (1) CN1157387C (pt)
AR (1) AR028306A1 (pt)
AT (1) ATE242226T1 (pt)
AU (1) AU777616B2 (pt)
BR (1) BR0101230B1 (pt)
CA (1) CA2342950C (pt)
DE (1) DE60100321T2 (pt)
DK (1) DK1138677T3 (pt)
EA (1) EA003770B1 (pt)
ES (1) ES2201019T3 (pt)
FR (1) FR2807039A1 (pt)
HK (1) HK1039618B (pt)
HU (1) HU228204B1 (pt)
NO (1) NO318088B1 (pt)
NZ (1) NZ510857A (pt)
PL (1) PL212886B1 (pt)
PT (1) PT1138677E (pt)
SI (1) SI1138677T1 (pt)
ZA (1) ZA200102642B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6683072B1 (en) 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
ES2570597T3 (es) * 2005-10-17 2016-05-19 Generics Uk Ltd Proceso e intermedios para la preparación de Salmeterol
US9314469B2 (en) 2008-05-05 2016-04-19 Tonix Pharma Holdings Limited Method for treating neurocognitive dysfunction
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
WO2010070667A2 (en) * 2008-11-19 2010-06-24 Biophore India Pharmaceuticals Pvt. Ltd. Novel process for the preparation of 7-((3-chloro-6-methyl-5,5-dioxo-6,11-dihydrodibenzo(c,f)(1,2) thiazepin-11-yl)amino)heptanoate
KR101136976B1 (ko) * 2011-09-06 2012-05-30 건일제약 주식회사 티아넵틴 또는 그의 염을 포함하는 탈모증의 예방 또는 치료용 약학 조성물
GB201208315D0 (en) 2012-05-11 2012-06-27 Numedicus Ltd Pharmaceutical methods and compositions
CA2998868A1 (en) 2015-09-16 2017-03-23 The Trustees Of Columbia University In The City Of New York Carboxylic diarylthiazepineamines as mu-opioid receptor agonists
CN105254587B (zh) * 2015-10-21 2018-01-09 济南诚汇双达化工有限公司 一种噻萘普汀钠中间体的制备方法
WO2017165738A1 (en) 2016-03-25 2017-09-28 The Trustees Of Columbia University In The City Of New York Mitragynine alkaloids as opioid receptor modulators
WO2018170275A1 (en) * 2017-03-15 2018-09-20 The Trustees Of Columbia University In The City Of New York Carboxylic diarythiazepineamines as mixed mu-and delta-opioid receptor agonists
CN110790723A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 噻奈普汀钠的合成方法
KR20180101307A (ko) 2018-09-04 2018-09-12 지엘팜텍주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
KR102199871B1 (ko) 2018-12-21 2021-01-08 주식회사 한서켐 3,11-디클로로-6-메틸-6,11-디하이드로디벤조[c,f][1,2]티아제핀 5,5-디옥시드의 제조방법
KR20200104265A (ko) 2020-08-21 2020-09-03 지엘팜텍주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
CN112062733A (zh) * 2020-10-30 2020-12-11 南京法恩化学有限公司 一种噻萘普汀钠的制备方法
CN115872951A (zh) * 2022-12-25 2023-03-31 山东诚汇双达药业有限公司 一种噻奈普汀钠中间体甲氧基取代物的合成方法
CN115819375A (zh) * 2022-12-25 2023-03-21 山东诚汇双达药业有限公司 噻奈普汀钠关键中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1179108A (en) * 1966-12-19 1970-01-28 Science Union & Cie New Derivatives of Dibenzo (c,f) Thiazepine (1,2) and processes for manufacturing them
GB1269551A (en) 1969-03-27 1972-04-06 Science Union & Cie New tricyclic derivatives and process for their manufacture
CA995213A (fr) * 1972-03-16 1976-08-17 Charles Malen Procede de preparation de derives tricycliques
PL106752B1 (pl) * 1976-02-25 1980-01-31 Politechnika Gdanska Sposob otrzymywania nowych 1-nitro-9-alkiloaminoalkiloaminoakrydyn lub ich soli
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
KR890002073A (ko) * 1987-07-01 1989-04-07 원본미기재 나프토티아제핀온
RU2024509C1 (ru) * 1991-05-07 1994-12-15 Всероссийский научный центр по безопасности биологически активных веществ Производные 9-аминоакридина или их соли с органическими или неорганическими кислотами, проявляющие психотропную, антиамнестическую и липидрегулирующую активность
JPH05255290A (ja) * 1992-03-17 1993-10-05 Fujisawa Pharmaceut Co Ltd 腫瘍壊死因子産生阻害剤
FR2716623B1 (fr) * 1994-02-25 1996-08-23 Adir Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.
US5783584A (en) * 1995-12-11 1998-07-21 Mayo Foundation For Medical Education And Research THA analogs useful as cholinesterase inhibitors
US5886185A (en) * 1997-11-20 1999-03-23 Development Center For Biotechnoloy Polyamine-linked acridine dimers
GB2339778A (en) * 1998-07-17 2000-02-09 Secr Defence Terphenyl Liquid Crystals

Also Published As

Publication number Publication date
SI1138677T1 (en) 2003-10-31
NO20011598L (no) 2001-10-01
NO318088B1 (no) 2005-01-31
PT1138677E (pt) 2003-09-30
US20010037021A1 (en) 2001-11-01
AR028306A1 (es) 2003-05-07
ZA200102642B (en) 2001-10-05
EP1138677A1 (fr) 2001-10-04
DK1138677T3 (da) 2003-09-29
PL212886B1 (pl) 2012-12-31
CN1157387C (zh) 2004-07-14
EA200100301A3 (ru) 2001-12-24
EP1138677B1 (fr) 2003-06-04
DE60100321T2 (de) 2004-04-29
HU0101334D0 (en) 2001-06-28
JP2001316380A (ja) 2001-11-13
JP3723464B2 (ja) 2005-12-07
NO20011598D0 (no) 2001-03-29
ES2201019T3 (es) 2004-03-16
EA200100301A2 (ru) 2001-10-22
FR2807039A1 (fr) 2001-10-05
EA003770B1 (ru) 2003-08-28
HUP0101334A3 (en) 2004-11-29
NZ510857A (en) 2001-08-31
HK1039618A1 (en) 2002-05-03
AU777616B2 (en) 2004-10-21
HU228204B1 (en) 2013-01-28
DE60100321D1 (de) 2003-07-10
PL346793A1 (en) 2001-10-08
US6441165B2 (en) 2002-08-27
KR100464180B1 (ko) 2004-12-31
BR0101230B1 (pt) 2013-12-24
CA2342950A1 (fr) 2001-09-30
ATE242226T1 (de) 2003-06-15
KR20010095040A (ko) 2001-11-03
CN1319593A (zh) 2001-10-31
AU3336801A (en) 2001-10-04
HK1039618B (zh) 2004-12-31
CA2342950C (fr) 2007-05-08
HUP0101334A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
BR0101230A (pt) Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina
BR0109836A (pt) Processo de sìntese de perindopril e de seus sais farmaceuticamente aceitáveis
NO20035327D0 (no) Biologisk aktive metylen-blått derivater
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
BR0108893A (pt) Composição farmacêutica, composto e processo de preparação de compostos
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
ATE297203T1 (de) Antithrombotische mitteln
BR0112395A (pt) Derivados de benzotiazol
BR0307267A (pt) Compostos heterocìclicos, ativos como inibidores de beta-lacta-mases
HK1048474A1 (en) Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones.
BR0212069A (pt) Agentes antidiabéticos orais
BR9810657A (pt) "processo de preparação de um per-hidroisoindol substituìdo"
MXPA04006041A (es) Antivirales de piridoquinoxalina.
BR9905089A (pt) Derivados macrolìdeos
BR0215067A (pt) Piridoquinoxalinas antivirais
DK1059283T3 (da) Fremgangsmåde til fremstilling af neuraminidase-inhibitor ro-64-0796
ATE308540T1 (de) Antithrombosemittel
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
DE60216948D1 (en) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
MY129094A (en) Condensed polycyclic compounds
BR0107483A (pt) Processo para a preparação de um composto
BR0101439A (pt) Derivados de eritromicina a
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina

Legal Events

Date Code Title Description
PC Transfer

Free format text: LES LABORATOIRES SERVIER (FR)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: C07D 281/02

Ipc: C07D 281/02 (2010.01), C07D 281/12 (2010.01), C07D

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/12/2013, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2507 DE 22-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.